COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal modelsAntonella Conforti, Maria Rosaria Capobianchi, Eleonora Pinto et al.|Molecular Therapy|2021Cited by 70
The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effectsGiuliana Cassinelli, Franco Zunino, Valentina Zuco et al.|Biochemical Pharmacology|2012Cited by 31
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike ProteinEmanuela D’Acunto, Giuseppe Roscilli, Alessia Muzi et al.|Antibodies|2024Cited by 3
COVID- <i>e</i> Vax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19Antonella Conforti, Maria Rosaria Capobianchi, Emanuele Marra et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2
Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic ActivityAlessia Muzi, Giuseppe Roscilli, Roberto Arriga et al.|Antibodies|2025Cited by 1